GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eone Diagnomics Genome Center Co Ltd (XKRX:245620) » Definitions » Price-to-Owner-Earnings

Eone Diagnomics Genome Center Co (XKRX:245620) Price-to-Owner-Earnings : (As of May. 28, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Eone Diagnomics Genome Center Co Price-to-Owner-Earnings?

As of today (2024-05-28), Eone Diagnomics Genome Center Co's share price is ₩415.00. Eone Diagnomics Genome Center Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings or its related term are showing as below:


XKRX:245620's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.86
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-28), Eone Diagnomics Genome Center Co's share price is ₩415.00. Eone Diagnomics Genome Center Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-379.62. Therefore, Eone Diagnomics Genome Center Co's PE Ratio for today is At Loss.

As of today (2024-05-28), Eone Diagnomics Genome Center Co's share price is ₩415.00. Eone Diagnomics Genome Center Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-185.54. Therefore, Eone Diagnomics Genome Center Co's PE Ratio without NRI for today is At Loss.


Eone Diagnomics Genome Center Co Price-to-Owner-Earnings Historical Data

The historical data trend for Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eone Diagnomics Genome Center Co Price-to-Owner-Earnings Chart

Eone Diagnomics Genome Center Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

Eone Diagnomics Genome Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings falls into.



Eone Diagnomics Genome Center Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=415.00/-522.43
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eone Diagnomics Genome Center Co  (XKRX:245620) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Eone Diagnomics Genome Center Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Eone Diagnomics Genome Center Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Eone Diagnomics Genome Center Co (XKRX:245620) Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, 291 Harmony-ro, Yeonsu-Gu, Incheon, KOR, 22014
Eeone Diagnomics Genome Center Co Ltd is engaged in developing and personalizing medicine based on Next Generation Sequencing technology and cutting edge genomics analysis. The company provides various personal genome sequencing and bioinformatics solutions to biomedical researchers, physicians and individuals seeking to understand the genetic influence of personal health and disease.

Eone Diagnomics Genome Center Co (XKRX:245620) Headlines

No Headlines